Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEMSO: Teriflunomide in Relapsing Multiple Sclerosis
NCT00134563Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2004
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of teriflunomide in multiple sclerosis (MS), sponsored by Sanofi. Started Sep 2004; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00134563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134563.